ReePrime
Major Price Target Changes for Thursday

Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.

Major Price Target Changes for Thursday

B
Benzinga

786 Views • Mar 03, 2022

Description

Price targets change all the time, but it can be difficult for investors to keep up with a fluctuating market that seems almost too agile to predict. Looking through the 10 biggest price target changes for Thursday can help you make wise decisions going forward. Piper Sandler ($PIPR@US) cut its price target on Bright Health Group ($BHG@US) from $10 to $5. Needham cut C3.ai from $103 all the way down to $26 as the stock fell even in premarket activity. SVB Leerink ($SIVB@US) cut its target on Gemini Therapeutics ($GMTX@US) from $10 to $2 and Credit Suisse ($CS@Switzerland) cut its price target for Snowflake Inc ($SNOW@US) from $465 per share to $415 per share. Finally, HC Wainwright cut its price target on Novavax ($NVAX@US) from $294 to $207. On the other side, RBC Capital ($RY@Canada) increased its price target on Biogen ($BIIB@US) from $227 to $248. Keybanc raised its price target on ConocoPhillips ($COP@US) from $98 to $106, and BMO Capital ($BMO@Canada) raised its price target on Ball Corporation ($BLL@US) from $87 to $105. At press time, Ball Corporation stock was trading at just over $88, up more than a percent in early activity.